Directory

>

Michelle Blake

avatar

Michelle Blake

Vice President, Translational Sciences | Sonoma Biotherapeutics

Seattle, Washington, United States

View contact details (it's free)

Michelle Blake

Summary

Michelle Blake is a seasoned leader in the biopharmaceutical industry with extensive experience in drug development, particularly in translational sciences. Currently serving as Vice President at Sonoma Biotherapeutics, she spearheads research initiatives focused on innovative therapies for oncology. With a Ph.D. in Pathology from the University of Washington, Michelle has a strong technical background in various areas including immunology, biomarker development, and drug discovery. Her career spans several prominent organizations, where she has held leadership roles that emphasize her expertise in CAR-T therapies and antibody technologies. Notably, she contributed to the approval of significant drug products during her tenure at Amgen. Michelle is passionate about advancing translational medicine and is committed to bridging the gap between research and clinical application. Her ability to lead cross-functional teams and manage complex projects has been a hallmark of her professional journey, making her a key player in the biotherapeutics landscape.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Michelle Blake

Work Experience

company logo

Vice President, Translational Sciences at

Sonoma Biotherapeutics

October 2021 - Present

company logo

Senior Director at

Shape Therapeutics Inc.

April 2020 - October 2021

company logo

Director, Immuno-oncology & Cellular Therapy Translational Sciences at

Bristol Myers Squibb

March 2018 - March 2020

company logo

Principal Scientist, Biomarkers at

Bristol Myers Squibb

July 2016 - March 2018

company logo

Senior Manager, Diagnostics & Biomarkers at

Seagen

November 2015 - June 2016

company logo

Lead Scientist Translational Research at

Emergent BioSolutions

September 2014 - October 2015

company logo

Senior Scientist Biomarkers at

ImmunoGen, Inc.

January 2014 - August 2014

company logo

Associate Director, Pharmacology at

Agios Pharmaceuticals

May 2012 - January 2014

company logo

Senior Scientist at

Amgen, Inc.

January 2005 - October 2011

company logo

Scientist at

Amgen, Inc.

July 2004 - December 2004

💼

Postdoctoral Fellow at

Amgenimmunex

January 2002 - January 2004

Logos provided by Logo.dev

Michelle Blake

Education

University of Washington, Ph.D.

January 1995 - January 2001

California Polytechnic State University, San Luis Obispo, Bachelor Of Science

January 1989 - January 1993

Frequently Asked Questions about Michelle Blake

What is Michelle Blake email address?

Michelle Blake's primary email address is **************@waikato.ac.nz. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Michelle Blake work for?

Michelle Blake is a Vice President, Translational Sciences at Sonoma Biotherapeutics, a company specializing in Commercial physical research.

Where Michelle Blake graduated from?

Michelle Blake holds a degree in Pathology from University of Washington.

How can I directly contact Michelle Blake?

To contact Michelle Blake directly, you can use the email address **************@waikato.ac.nz. Complete contact information is available upon registration with Muraena.

Who is Michelle Blake?

Michelle Blake is a seasoned leader in the biopharmaceutical industry with extensive experience in drug development, particularly in translational sciences. Currently serving as Vice President at Sonoma Biotherapeutics, she spearheads research initiatives focused on innovative therapies for oncology. With a Ph.D. in Pathology from the University of Washington, Michelle has a strong technical background in various areas including immunology, biomarker development, and drug discovery. Her career spans several prominent organizations, where she has held leadership roles that emphasize her expertise in CAR-T therapies and antibody technologies. Notably, she contributed to the approval of significant drug products during her tenure at Amgen. Michelle is passionate about advancing translational medicine and is committed to bridging the gap between research and clinical application. Her ability to lead cross-functional teams and manage complex projects has been a hallmark of her professional journey, making her a key player in the biotherapeutics landscape.

Michelle`s contact details

mail

**************@waikato.ac.nz

******@sonomabio.com

Colleagues

avatar
Anavelys Ortiz-Suárez

Vice President, Intellectual Property and Legal Operations

avatar
Sabrina Fox-Bosetti

Vice President Clinical Operations

Susan Lacy

Vice President Discovery

avatar
Sameer Sivaamnuaiphorn

Vice President, Program Leadership

Joshua Beilke

Vice President

avatar
Melita Dvorak-Ewell

VP Program Management

avatar
Diana Roses

Vice President, Head Of Quality

avatar
Doug Sheehy

Chief Legal Officer & Secretary

avatar
David Gold

Vice President Of Business Development

avatar
Joe Arron

Chief Scientific Officer

View Contact details (it's free)
Request Profile Removal